APA

Lu K., Yin M. B., McGuire J. J., Bonmassar E. & Rustum Y. M. (19950919). Mechanisms of resistance to N-[5-[N-(3,4-dihydro-2-methyl-4- oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell line. : Biochemical pharmacology.

Chicago

Lu K, Yin M B, McGuire J J, Bonmassar E and Rustum Y M. 19950919. Mechanisms of resistance to N-[5-[N-(3,4-dihydro-2-methyl-4- oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell line. : Biochemical pharmacology.

Harvard

Lu K., Yin M. B., McGuire J. J., Bonmassar E. and Rustum Y. M. (19950919). Mechanisms of resistance to N-[5-[N-(3,4-dihydro-2-methyl-4- oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell line. : Biochemical pharmacology.

MLA

Lu K, Yin M B, McGuire J J, Bonmassar E and Rustum Y M. Mechanisms of resistance to N-[5-[N-(3,4-dihydro-2-methyl-4- oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl]-L-glutamic acid (ZD1694), a folate-based thymidylate synthase inhibitor, in the HCT-8 human ileocecal adenocarcinoma cell line. : Biochemical pharmacology. 19950919.